Growth Metrics

Nu-Med Plus (NUMD) Return on Capital Employed (2016 - 2025)

Nu-Med Plus' Return on Capital Employed history spans 9 years, with the latest figure at 712.47% for Q4 2021.

  • On a quarterly basis, Return on Capital Employed rose 109715.0% to 712.47% in Q4 2021 year-over-year; TTM through Dec 2021 was 712.47%, a 109715.0% increase, with the full-year FY2021 number at 621.22%, up 28615.0% from a year prior.
  • Return on Capital Employed hit 712.47% in Q4 2021 for Nu-Med Plus, down from 2413.52% in the prior quarter.
  • Over the last five years, Return on Capital Employed for NUMD hit a ceiling of 12378.27% in Q1 2018 and a floor of 14129.23% in Q2 2018.
  • Historically, Return on Capital Employed has averaged 264.72% across 5 years, with a median of 102.26% in 2017.
  • Biggest five-year swings in Return on Capital Employed: plummeted -1403477bps in 2018 and later soared 1473181bps in 2019.
  • Tracing NUMD's Return on Capital Employed over 5 years: stood at 3401.7% in 2017, then crashed by -131bps to 1049.72% in 2018, then skyrocketed by 128bps to 290.03% in 2019, then crashed by -233bps to 384.68% in 2020, then skyrocketed by 285bps to 712.47% in 2021.
  • Business Quant data shows Return on Capital Employed for NUMD at 712.47% in Q4 2021, 2413.52% in Q3 2021, and 1624.23% in Q2 2021.